BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32152677)

  • 1. Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis.
    Salman MA; Mikhail HMS; Nafea MA; Sultan AAEA; Elshafey HE; Tourky M; Awad A; Abouelregal TE; Ahmed RA; Ashoush O; AbdelAal AA; Shaaban HE; Atallah M; Yousef M; Salman AA
    Surg Endosc; 2021 Mar; 35(3):1269-1277. PubMed ID: 32152677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD.
    Salman MA; Salman AA; Abdelsalam A; Atallah M; Shaaban HE; El-Mikkawy A; Omar MG; Elshenoufy M
    Obes Surg; 2020 Jan; 30(1):87-95. PubMed ID: 31372873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Laparoscopic Sleeve Gastrectomy on Non-Alcoholic Steatohepatitis and Liver Fibrosis in Japanese Patients with Severe Obesity.
    Nikai H; Ishida K; Umemura A; Baba S; Nitta H; Sugai T; Sasaki A
    Obes Surg; 2020 Jul; 30(7):2579-2587. PubMed ID: 32124215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis.
    Manco M; Mosca A; De Peppo F; Caccamo R; Cutrera R; Giordano U; De Stefanis C; Alisi A; Baumann U; Silecchia G; Nobili V
    J Pediatr; 2017 Jan; 180():31-37.e2. PubMed ID: 27697327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of sleeve gastrectomy for non-alcoholic steatohepatitis estimated by paired liver biopsy in morbidly obese Japanese patients.
    Murakami E; Nakahara T; Hiramatsu A; Morio K; Fujino H; Yamauchi M; Kawaoka T; Tsuge M; Imamura M; Aikata H; Fudeyasu K; Nakashima Y; Iwaki D; Jodai D; Ohigashi T; Nishimura Y; Minamoto Y; Nagao A; Yoneda M; Saeki Y; Tanabe K; Ohdan H; Chayama K
    Medicine (Baltimore); 2021 Jul; 100(26):e26436. PubMed ID: 34190166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis.
    Lassailly G; Caiazzo R; Ntandja-Wandji LC; Gnemmi V; Baud G; Verkindt H; Ningarhari M; Louvet A; Leteurtre E; Raverdy V; Dharancy S; Pattou F; Mathurin P
    Gastroenterology; 2020 Oct; 159(4):1290-1301.e5. PubMed ID: 32553765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation.
    Cabré N; Luciano-Mateo F; Fernández-Arroyo S; Baiges-Gayà G; Hernández-Aguilera A; Fibla M; Fernández-Julià R; París M; Sabench F; Castillo DD; Menéndez JA; Camps J; Joven J
    Metabolism; 2019 Oct; 99():81-89. PubMed ID: 31279739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study).
    Lavín-Alconero L; Fernández-Lanas T; Iruzubieta-Coz P; Arias-Loste MT; Rodriguez-Duque JC; Rivas C; Cagigal ML; Montalbán C; Useros AL; Álvarez-Cancelo A; García-Saiz M; Crespo-García J
    Trials; 2021 Oct; 22(1):756. PubMed ID: 34717726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels.
    Salman AA; Sultan AAEA; Abdallah A; Abdelsalam A; Mikhail HMS; Tourky M; Omar MG; Youssef A; Ahmed RA; Elkassar H; Seif El Nasr SM; Shaaban HE; Atallah M; GabAllah GMK; Salman MA
    J Gastroenterol Hepatol; 2020 Oct; 35(10):1769-1773. PubMed ID: 32153044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic Sleeve Gastrectomy Resolves NAFLD: Another Formal Indication for Bariatric Surgery?
    Esquivel CM; Garcia M; Armando L; Ortiz G; Lascano FM; Foscarini JM
    Obes Surg; 2018 Dec; 28(12):4022-4033. PubMed ID: 30121855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
    Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
    Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients with Obesity.
    Elyasinia F; Jalali SM; Zarini S; Sadeghian E; Sorush A; Pirouz A
    Middle East J Dig Dis; 2021 Jul; 13(3):200-207. PubMed ID: 36606220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
    Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
    Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy.
    Ramos-Molina B; Castellano-Castillo D; Pastor O; Ocaña-Wilhelmi L; Fernández-García D; Romero-Gómez M; Cardona F; Tinahones FJ
    Obes Surg; 2019 Mar; 29(3):983-989. PubMed ID: 30488259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of NAFLD and fibrosis in obese patients - a comparison of histological and clinical scoring systems.
    Schmitz SM; Kroh A; Ulmer TF; Andruszkow J; Luedde T; Brozat JF; Neumann UP; Alizai PH
    BMC Gastroenterol; 2020 Aug; 20(1):254. PubMed ID: 32758151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery.
    Pais R; Aron-Wisnewsky J; Bedossa P; Ponnaiah M; Oppert JM; Siksik JM; Genser L; Charlotte F; Thabut D; Clement K; Ratziu V
    Hepatology; 2022 Aug; 76(2):456-468. PubMed ID: 35076966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association of Histologic and Noninvasive Tests With Adverse Clinical and Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis.
    Younossi ZM; Anstee QM; Wai-Sun Wong V; Trauner M; Lawitz EJ; Harrison SA; Camargo M; Kersey K; Subramanian GM; Myers RP; Stepanova M
    Gastroenterology; 2021 Apr; 160(5):1608-1619.e13. PubMed ID: 33307033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic sleeve gastrectomy in patients with NASH-related cirrhosis: a case-matched study.
    Rebibo L; Gerin O; Verhaeghe P; Dhahri A; Cosse C; Regimbeau JM
    Surg Obes Relat Dis; 2014; 10(3):405-10; quiz 565. PubMed ID: 24355322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.